Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olympic Investments is an investment organization rather than an operating biotechnology, pharmaceutical, or healthcare company. Available public profiles describe it as the private investment arm of the Onassis Foundation, with activity spanning venture and growth investments across multiple sectors, including some health-related investments. It does not appear to develop its own therapeutic products, run a drug pipeline, or operate as a CRO, CDMO, biotech, or pharma company. For biotech diligence purposes, it is best classified as an investor with occasional exposure to life sciences rather than a healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olympic Investments.